MetaCap

Viemed Healthcare Inc. (VMD)

NASDAQ: VMDHealth CareMisc Health and Biotechnology ServicesUSD

8.52-0.09 (-1.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$322.85M
52-week range
6.60 – 12.61
Day range
8.47 – 8.75
Volume / Avg
258.85K / 247.43K
Beta
—

52-week range

$6.60$12.61

VMD stock today

Viemed Healthcare (VMD) closed at $8.52 on Nov 20, down 1.05% (-$0.09), versus the S&P 500's 3.70% decline. Shares are 32.4% below their 52-week high of $12.61, set on Jul 13, 2026 and 29.1% above the 52-week low of $6.60, in the middle of the past year's range. VMD is up 14.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 27.9%.

At 22.4x trailing earnings, Viemed Healthcare trades below the peer-group median of 26.5x. Its forward P/E of 21.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Viemed Healthcare

Company profile

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment.

Industry
Misc Health and Biotechnology Services
CEO
Mr. Casey Hoyt
Headquarters
Lafayette, LA
Employees
1,490
Website
viemed.com

Financial highlights

Full financials

In fiscal 2025, Viemed Healthcare generated $270.3 million in revenue, up 20.5% from fiscal 2024, its 4th consecutive year of revenue growth. Net income was $14.9 million (+32.6% year over year), for a net margin of 5.5% versus a median of 5.6% in the prior 5 years. Gross margin was 57.5% (down from 59.4%) and operating margin 8.5%.

Viemed Healthcare annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$270.28M$224.26M$183.01M$138.83M$117.06M
Growth+20.52%+22.54%+31.82%+18.60%-10.85%
Net income$14.93M$11.27M$10.24M$6.22M$9.13M
EPS (diluted)$0.37$0.28$0.25$0.16$0.22

Analyst forecast

Forecast

Consensus (2 analysts)

buy

Avg. price target

$12.00+40.85%

  • Strong buy 1
  • Buy 0
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $10.00High $14.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.11 vs $0.12
Surprise
-8.33%

VMD news

All VMD news

Viemed Healthcare peers

Health Care sector
VMD peer companies
CompanyPrice% ChgMarket capCompare
PARKPark Dental Partners Inc.17.03-6.79%$94.26Mvs VMD
CCELCryo-Cell International Inc.4.150.00%$33.46Mvs VMD
MGRXMangoceuticals Inc.0.1236-7.55%$2.75Mvs VMD
NIVFNewGenIvf Group Limited Class A0.0269-23.14%$80.77Kvs VMD
AGLagilon health inc.90.24+0.83%$1.52Bvs VMD
PGNYProgyny Inc.35.71+0.73%$2.63Bvs VMD
SHCSotera Health Company15.91-1.85%$4.54Bvs VMD
DVADaVita Inc.161.03+3.00%$10.13Bvs VMD

Indexes, lists and sector

Viemed Healthcare stock FAQ

What is Viemed Healthcare's stock price today?

VMD last traded at $8.52 as of Nov 20, 4:00 PM EST, down 1.05% on the day. Prices are delayed at least 15 minutes.

What is VMD's P/E ratio?

VMD trades at a trailing P/E ratio of 22.42 and a forward P/E of 21.30, compared with a median of 26.5 for its closest peers.

Who is Viemed Healthcare's CEO?

Mr. Casey Hoyt is the chief executive officer of Viemed Healthcare Inc., which has about 1,490 employees.

What is the VMD 52-week high?

The 52-week high for VMD is $12.61 and the 52-week low is $6.60. The stock is currently 32.4% below its high.

Compare VMD